Toll-like receptor 4, a potential therapeutic target of lower limb ischemic myopathy that raises further questions

• Ali H. Hakim, MD,
• Ulf Hedin, MD, PhD

Affiliations

Ali H. Hakim, MD

Division of Vascular Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, NE

Ulf Hedin, MD, PhD

Division of Vascular Surgery, Department of Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden